NCT05533840

Brief Summary

Tinnitus, hearing loss and vertigo are the three major diseases of otology, affecting hundreds of millions of people in our country, and are major health problems. Ear structures and lesions are deeply embedded in the bone, and CT is the preferred examination technique. The key structures of the ear are small and the lesions are hidden. Spiral CT is "not visible" and "undiagnosed" due to insufficient spatial resolution. The ultra-high-resolution CT independently developed by our team has a spatial resolution of 50 μm, which is 6 times higher than that of high-end spiral CT, and solves the problem of "not showing" ear diseases. However, with the transformation of imaging modes and the improvement of display capabilities, the imaging system of helical CT is no longer applicable. It is urgent to carry out systematic research to create matching imaging plans, imaging anatomy standards and disease assessment standards to solve the problem of "undiagnosed". problem. This project plans to build an adult and pediatric imaging solution based on ultra-high-resolution CT to optimize image quality and radiation dose; comprehensively evaluate conduction, sensory, and surgical-related fine structures of the ear, and establish a new 0.1mm-scale image anatomy atlas; A prospective study conducted by the center analyzes the hidden pathological changes of tinnitus, deafness and vertigo, evaluates the diagnostic efficacy of ultra-high-resolution CT for the above diseases, and establishes new diagnostic criteria for lesion detection, symptom correlation, and efficacy evaluation. This project will bring new changes to the practice of otology clinical diagnosis and treatment

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 9, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 9, 2022

Status Verified

September 1, 2022

Enrollment Period

2.3 years

First QC Date

August 30, 2022

Last Update Submit

September 5, 2022

Conditions

Keywords

OtologyMedical imagingTomography, X-rayDiagnosisResolution

Outcome Measures

Primary Outcomes (5)

  • Subjective and objective evaluation methods for CT image quality

    Image quality (Likert score) and image noise will be combined to report the optimal image quality-noise combination

    2022.1-2024.12

  • Radiological anatomy of normal ears based on ultra-high resolution CT

    diameters in milimeter

    2022.1-2024.12

  • Radiological anatomy of normal ears based on ultra-high resolution CT

    angle in degree

    2022.1-2024.12

  • Quantitative diagnostic standard for ear diseases based on U-HRCT image

    shape and position of conductive and senserineural hearing pathways

    2022.1-2024.12

  • Quantitative diagnostic standard for ear diseases based on U-HRCT image

    size in milimeter of conductive and senserineural hearing pathways

    2022.1-2024.12

Study Arms (6)

Age under 18

Participants under the age of 18

Diagnostic Test: ultra-high-resolution computed tomography exams

Age 18-30

Participants aged 18-30

Diagnostic Test: ultra-high-resolution computed tomography exams

Age 31-40

Participants aged 31-40

Diagnostic Test: ultra-high-resolution computed tomography exams

Age 41-50

Participants aged 41-50

Diagnostic Test: ultra-high-resolution computed tomography exams

Age 51-60

Participants aged 51-60

Diagnostic Test: ultra-high-resolution computed tomography exams

Age ≥61

Participants aged ≥61

Diagnostic Test: ultra-high-resolution computed tomography exams

Interventions

Participants in the age groups undergo ultra-high-resolution computed tomography exam

Age 18-30Age 31-40Age 41-50Age 51-60Age under 18Age ≥61

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* 50 healthy volunteers (100 ears) * otological patients 1450 cases (tinnitus\>634 ears, hearing loss\>634 ears, and vertigo\>181 ears)

You may qualify if:

  • Meet the ethical requirements of U-HRCT examination
  • Can cooperate to complete U-HRCT examination
  • There is no relevant medical history in the side ear scanned

You may not qualify if:

  • Clinical symptoms related to middle and inner ear lesions, such as conduction deafness, sensorineural hearing loss, mixed deafness, vertigo, etc.
  • Congenital inner ear malformation
  • Diseases causing bone changes around the middle and inner ear, such as otitis media, tumors , otosclerosis, fibrous dysplasia, etc.
  • history of previous ear surgery and trauma
  • CT image artifacts or incomplete scan coverage
  • incomplete clinical data
  • For patients with otological diseases
  • Due to tinnitus/deafness/peripheral vertigo/peripheral facial paralysis in the ENT department of our hospital
  • Meet the ethical requirements of U-HRCT examination
  • Can cooperate with the completion of U-HRCT examination
  • Surgery in the ENT department of our hospital
  • At least one follow-up or re-examination after discharge
  • History of previous ear surgery and trauma
  • CT image artifacts or incomplete scanning coverage
  • Incomplete clinical data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, 100050, China

RECRUITING

MeSH Terms

Conditions

Hearing LossTinnitusVertigoDisease

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsVestibular DiseasesLabyrinth DiseasesPathologic Processes

Study Officials

  • Zhenchang Wang, Prof.

    Beijing Friendship Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pengfei Zhao, Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice President, Director of Medical Imaging Center

Study Record Dates

First Submitted

August 30, 2022

First Posted

September 9, 2022

Study Start

September 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

September 9, 2022

Record last verified: 2022-09

Locations